Clinical Trial Update: Improving Immunosuppressive Treatment for Patients With Severe Aplastic Anemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating improved immunosuppressive treatment for severe aplastic anemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Severe Aplastic Anemia | Phase 2 | Status: COMPLETED